Related Experiment Videos
Corticosteroid therapy in patients with brain tumors
National Cancer Institute Monograph
|December 1, 1977
Summary
Corticosteroids help reduce brain tumor swelling and may directly fight tumor cells. However, they can complicate treatment response assessment and have potential side effects like bleeding.
Area of Science:
- Neuro-oncology
- Pharmacology
Background:
- Corticosteroids are widely used in brain tumor patients.
- Their exact mechanism of benefit remains debated.
- Evidence suggests both anti-edema and direct anti-neoplastic effects.
Purpose of the Study:
- To review the clinical utility of corticosteroids in brain tumor management.
- To discuss the proposed mechanisms of action.
- To highlight the challenges and benefits of corticosteroid therapy.
Main Methods:
- Review of existing literature on corticosteroid use in brain tumors.
- Discussion of experimental evidence for direct anti-neoplastic effects.
- Analysis of clinical observations regarding efficacy and side effects.
Main Results:
- Corticosteroids effectively reduce peritumoral edema.
- Steroids may possess direct cytotoxic effects on brain tumor cells.
- Therapy can interfere with the evaluation of concurrent anti-cancer treatments.
- Dosage requirements vary significantly among patients.
- Potential for increased gastrointestinal bleeding risk exists.
Conclusions:
- Corticosteroids offer significant clinical benefits in brain tumor patients, primarily by reducing edema.
- While direct anti-neoplastic effects are suggested, further research is needed.
- Careful consideration of dosage, individual response variability, and potential drug interactions is crucial.
- The benefits of corticosteroid therapy generally outweigh the risks, including a low risk of gastrointestinal bleeding.